New Plavix Warning: Lack of Effect in Many People
The anti-clotting drug Plavix will get a new "black box" label warning that normal doses don't work for 2% to 14% of patients.

U.S. Sees Spike in Nonmelanoma Skin Cancers
In thinking about skin cancer, the deadliest form, melanoma, often comes to mind. But a new study suggests the importance of focusing on less lethal types as well.